Lung Metastases From Colorectal Cancer: Analysis of Prognostic Factors in a Single Institution Study Maria Giulia Zampino, MD, Patrick Maisonneuve, Eng,

Slides:

Advertisements

Similar presentations

Lymphovascular Invasion as a Prognostic Indicator in Stage I Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis Nathan M. Mollberg, DO,

Advertisements

Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine.

Bronchopleural Fistula After Pneumonectomy: Risk Factors and Management, Focusing on Open-Window Thoracostomy Antonio Mazzella, MD, Alessandro Pardolesi,

Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.

Masatsugu Hamaji, MD, Stephen D. Cassivi, MD, K

Now or Later: Evaluating the Importance of Chemotherapy Timing in Resectable Stage III (N2) Lung Cancer in the National Cancer Database Daniel J. Boffa,

Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications? Francesco Leo, MD, Piergiorgio Solli,

Prediction of Prognosis and Surgical Indications for Pulmonary Metastasectomy From Colorectal Cancer Toshihiko Iizasa, MD, Makoto Suzuki, MD, Shigetoshi.

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

Radio-Guided Localization and Resection of Small or Ill-Defined Pulmonary Lesions Domenico Galetta, MD, PhD, Massimo Bellomi, MD, Chiara Grana, MD, Lorenzo.

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma Giulio Melloni, MD, Claudio.

Salvage Lung Resection After Definitive Radiation (>59 Gy) for Non-Small Cell Lung Cancer: Surgical and Oncologic Outcomes Julie E. Bauman, MD, Michael.

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection Bing-sheng Sun, MD, PhD, Yue.

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Glasgow Prognostic Score Class 2 Predicts Prolonged Intensive Care Unit Stay in Patients Undergoing Pneumonectomy Francesco Petrella, MD, Davide Radice,

The Model for End-Stage Liver Disease (MELD) Predicts Early and Late Outcomes of Cardiovascular Operations in Patients With Liver Cirrhosis Naoto Morimoto,

Factors Predicting Recurrence and Postrecurrence Survival in Completely Resected Thymic Carcinoma Yi-Ting Yen, MD, Wu-Wei Lai, MD, Kai-Wei Chang, MD,

Jong Ho Cho, MD, Masatsugu Hamaji, MD, Mark S. Allen, MD, Stephen D

Risk Factors for Lymph Node Metastases and Prognosticators of Survival in Patients Undergoing Pulmonary Metastasectomy for Colorectal Cancer Servet Bölükbas,

Prognostic Predictors in Non-Small Cell Lung Cancer Patients Undergoing Intentional Segmentectomy Terumoto Koike, MD, PhD, Teruaki Koike, MD, PhD, Yasushi.

Adding Radiotherapy to Adjuvant Chemotherapy Does Not Improve Survival of Patients With N2 Lung Cancer Justin A. Drake, MD, David C. Portnoy, MD, Kurt.

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Long-Term Survival After Salvage Surgery for Colorectal Lung Metastases Pietro Fabio Presicci, MD, Giulia Veronesi, MD, Massimiliano D'Aiuto, MD, Lorenzo.

Readmission to Intensive Care Unit After Initial Recovery From Major Thoracic Oncology Surgery Suk-Won Song, MD, Hyun-Sung Lee, MD, PhD, Jae-Hyun Kim,

“Circular clamp” excision: A new technique for lung metastasectomy

Long-Term Outcomes After Surgical Resection of Pulmonary Metastases From Colorectal Cancer Hisashi Suzuki, MD, PhD, Moriyuki Kiyoshima, MD, Miyuki Kitahara,

Prognostic role of lymph node involvement in lung metastasectomy

Extrapleural Pneumonectomy for Malignant Mesothelioma: An Italian Multicenter Retrospective Study Lorenzo Spaggiari, MD, PhD, Giuseppe Marulli, MD, Pietro.

Lung Cancer and Its Operable Brain Metastasis: Survival Rate and Staging Problems József Furák, MD, PhD, Imre Troján, MD, Tamás Szöke, MD, László Agócs,

Observational Study on the Beneficial Effect of Preoperative Statins in Reducing Atrial Fibrillation After Coronary Surgery Giovanni Mariscalco, MD,

Giant Alveolar Adenoma Causing Severe Dyspnoea

Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma Shinsuke Sasada, MD, PhD, Yoshihiro Miyata, MD, PhD,

Prognostic factors in clinical stage I non–small cell lung cancer

Characteristics Associated With the Use of Nonanatomic Resections Among Medicare Patients Undergoing Resections of Early-Stage Lung Cancer Anthony W.

Bilobectomy for Lung Cancer: Analysis of Indications, Postoperative Results, and Long- Term Outcomes Domenico Galetta, MD, PhD, Piergiorgio Solli, MD,

Age-Dependent Gender Disparities in Post Lung Transplant Survival Among Patients With Idiopathic Pulmonary Fibrosis Shahid I. Sheikh, MD, Don Hayes,

Use of Amiodarone After Major Lung Resection

A 10-Year Single-Center Experience on 708 Lung Metastasectomies: The Evidence of the “International Registry of Lung Metastases” Monica Casiraghi, MD,

Does Repeated Lung Resection Provide Long-Term Survival for Recurrent Pulmonary Metastases of Colorectal Cancer? Results of a Retrospective Japanese Multicenter.

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Lei Yu, MD, Tianxiang Gu, MD, PhD, Zongyi Xiu, MD, PhD

Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R

Prolonged Overall Survival After Pulmonary Metastasectomy in Patients With Breast Cancer Georgios Meimarakis, MD, Dominik Rüttinger, MD, PhD, Joachim.

Synchronous Primary Lung Cancer, Breast Cancer Recurrence, and Mediastinal Silicon- Induced Lymphadenitis Francesco Petrella, MD, Gian Carlo Pruneri,

Differences in Patterns of Recurrence in Early-Stage Versus Locally Advanced Non- Small Cell Lung Cancer Feiran Lou, MD, MS, Camelia S. Sima, MD, MS,

Lung Function and ECMO After Lung Transplantation

Predictors of Long-Term Survival After Resection of Esophageal Carcinoma With Nonregional Nodal Metastases Paul C. Lee, MD, Jeffrey L. Port, MD, Subroto.

Predictors of Nodal Metastases for Clinical T2N0 Esophageal Adenocarcinoma Arianna Barbetta, MD, Francisco Schlottmann, MD, Tamar Nobel, MD, David B.

Pulmonary Resection for Lung Cancer in Octogenarians

Sublobar Resection Provides an Equivalent Survival After Lobectomy in Elderly Patients With Early Lung Cancer Jiro Okami, MD, PhD, Yuri Ito, PhD, Masahiko.

“Salvage” Surgery for Primary Mediastinal Malignancies: Is it Worthwhile? Francesco Petrella, MD, Francesco Leo, MD, PhD, Giulia Veronesi, MD, Piergiorgio.

Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi.

Adjuvant Surgery after Carboplatin and VP16 in Resectable Small Cell Lung Cancer Giulia Veronesi, MD, Paolo Scanagatta, MD, Francesco Leo, MD, Tommaso.

Michael T. Durheim, MD, Sunghee Kim, PhD, Brian C

Predictors of Recurrent Pulmonary Metastases and Survival After Pulmonary Metastasectomy for Colorectal Cancer Shanda H. Blackmon, MD, MPH, Elizabeth.

Prognostic Analysis for Survival After Resections of Localized Primary Cardiac Sarcomas: A Single-Institution Experience Hua Li, MD, PhD, Deming Xu,

Surgical Techniques and Long-Term Results of Pulmonary Artery Reconstruction in Patients With Lung Cancer Domenico Galetta, MD, PhD, Alessandro Borri,

The Additional Prognostic Value of Left Atrial Volume on the Outcome of Patients After Surgical Ventricular Reconstruction Serenella Castelvecchio, MD,

Shared Decision Making and Effective Risk Communication in the High-Risk Patient With Operable Stage I Non-Small Cell Lung Cancer Pamela Samson, MD,

Prognostic Heterogeneity in Multilevel N2 Non-Small Cell Lung Cancer Patients: Importance of Lymphadenopathy and Occult Intrapulmonary Metastases Yukinori.

Role of Positron Emission Tomography/Computed Tomography Findings for Adjuvant Chemotherapy Indications in Stage T1b-2aN0M0 Lung Adenocarcinoma Shinsuke.

Mark I. Block, MD The Annals of Thoracic Surgery

Four-arm robotic lobectomy for the treatment of early-stage lung cancer Giulia Veronesi, MD, Domenico Galetta, MD, Patrick Maisonneuve, DipEng, Franca.

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Superior vena cava replacement for lung cancer using a heterologous (bovine) prosthesis: Preliminary results Lorenzo Spaggiari, MD, PhD, Domenico Galetta,

Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy Tomas Gudbjartsson,

Long-Term Results of Sleeve Lobectomy in the Management of Non–Small Cell Lung Carcinoma and Low-Grade Neoplasms Robert E. Merritt, MD, Douglas J. Mathisen,

Induction Chemoradiation Is Not Superior to Induction Chemotherapy Alone in Stage IIIA Lung Cancer Asad A. Shah, MD, Mark F. Berry, MD, Ching Tzao, MD,

Bryan M. Burt, MD, Santiago Ocejo, MD, Carlos M

Presentation transcript:

Lung Metastases From Colorectal Cancer: Analysis of Prognostic Factors in a Single Institution Study Maria Giulia Zampino, MD, Patrick Maisonneuve, Eng, Paola Simona Ravenda, MD, Elena Magni, MD, Monica Casiraghi, MD, Piergiorgio Solli, MD, Francesco Petrella, MD, Roberto Gasparri, MD, Domenico Galetta, MD, PhD, Alessandro Borri, MD, Stefano Donghi, MD, Giulia Veronesi, MD, Lorenzo Spaggiari, MD, PhD The Annals of Thoracic Surgery Volume 98, Issue 4, Pages 1238-1245 (October 2014) DOI: 10.1016/j.athoracsur.2014.05.048 Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Overall survival (A) after a first pulmonary metastasectomy overall, and (B) according to radicality of surgery. (CI = confidence interval.) The Annals of Thoracic Surgery 2014 98, 1238-1245DOI: (10.1016/j.athoracsur.2014.05.048) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Overall survival after a first R0 pulmonary metastasectomy according to selected patient characteristics: (A) stage of primary cancer; (B) disease-free interval; (C) number of metastases; (D) adjuvant chemotherapy (CT); and (E) hilar/mediastinal nodal status. (CI = confidence interval.) The Annals of Thoracic Surgery 2014 98, 1238-1245DOI: (10.1016/j.athoracsur.2014.05.048) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Overall survival after a first R0 pulmonary metastasectomy according to biomarkers: (A) carcinoembryonic antigen, and (B) K-RAS. (CI = confidence interval; Mut = mutation; WT = wild-type.) The Annals of Thoracic Surgery 2014 98, 1238-1245DOI: (10.1016/j.athoracsur.2014.05.048) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions

Fig 4 Overall survival after a first R0 pulmonary metastasectomy according to use of chemotherapy. (CI = confidence interval; Post = postoperative; Pre = preoperative.) The Annals of Thoracic Surgery 2014 98, 1238-1245DOI: (10.1016/j.athoracsur.2014.05.048) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions